Pregabalin Abuse amongst Opioid Substitution Treatment Patients.

Pregabalin (Lyrica®) is used in treating epilepsy, nerve pain and anxiety. Pregabalin was initially thought to have a low misuse potential however there are emerging reports of Pregabalin being abused. A study was commenced at the National Drug Treatment Centre's (NDTC) Drug Analysis Laboratory to determine the level of usage of Pregabalin within the addiction services population in Ireland. A total of 498 urine samples representing samples from 440 individual opioid substitution patients, initially screened by immunoassay for drugs of abuse, were subjected to further analysis for Pregabalin by Liquid Chromatography/Mass Spectrometry (LC/MS). Of 440 patients tested, 39 tested positive for Pregabalin (9.2%). Only 10 patients from this group were prescribed this drug to our knowledge thus giving an estimated rate of misuse of 7.0%. Other drugs detected in the Pregabalin positive patients were Opiates (31.8%), Cocaine (11.4%), Benzodiazepines (79.5%) and Cannabis (77.8%). Our study confirms that Pregabalin abuse is taking place amongst the addiction services population. We believe that misuse of this prescription drug is a serious emerging issue which should be monitored carefully.

Effects of different transition diets on dry matter intake, milk production, and milk composition in dairy cows.

The primary objective of this study was to evaluate the effect on dry matter intake (DMI), milk yield, milk composition, body weight (BW), and body condition score (BCS) change of cows offered diets differing in energy density in the last 4 wk of gestation and in the first 8 wk of lactation. Three diets (grass silage:straw, 75:25 on a dry matter basis (SS), grass silage (S), and grass silage + 3 kg concentrate daily (C)) precalving, and two diets (4 kg [LC] or 8 kg [HC] concentrate daily + grass silage ad libitum) postcalving were combined in a 3 x 2 factorial design. Sixty Holstein-Friesian cows entering their second lactation were blocked according to expected calving date and BCS into groups of six and were then allocated at random to the treatments. Individual feeding started 4 wk prior to the expected calving date and measurements were made until the end of the 8th wk of lactation. Mean DMI differed between each of the precalving treatments (7.4, 8.1, and 9.9 kg/d for SS, S, and C, respectively) in the precalving period. The DMI also differed between SS and C for wk 1 to 8 (13.5 and 14.2 kg/d) postcalving. Postcalving, milk (24.2, 26.2, and 28.2 kg/d), fat (933, 1063, and 1171 g/d), and protein (736, 797, and 874 g/d) yields differed between SS, S, and C, respectively. The BCS changes differed between SS and C (-0.09 and 0.12 of a BCS) in the precalving period and between SS and S compared with C (0.02, 0.06, and -0.26 of a BCS) for wk 1 to 8 postcalving. The BW change differed between SS and S compared with C in both wk 1 to 4 (-0.23, -0.37, and -1.25 kg/d) and wk 1 to 8 (0.18, 0.10, and -0.58 kg/ d) postcalving. The BW and BCS were lower at calving for cows on SS compared with C. The greater amount of concentrate supplement postcalving increased DMI, yields of milk, fat, and protein and decreased BW loss in the first 8 wk of lactation. In conclusion, these results indicate that a greater energy density diet in the final 4 wk of the dry period improves cow production in early lactation.

Effect of offering rumen-protected fat supplements on fertility and performance in spring-calving Holstein-Friesian cows.

The objective of this study was to evaluate the effect of two different rumen-protected fat supplements, on reproductive performance and milk production, in grass-based spring calving cows. Two hundred and one Holstein-Friesian cows with an average lactation number of 3.6 (20% first lactation, 16% second lactation and 64% third lactation or greater) were grouped into blocks of three on the basis of calving date, lactation number and previous lactation milk yield for cows of second lactation or greater and on the basis of calving date for first lactation animals. From within-blocks individual animals were assigned at random, within 10 days post-calving, to one of the following three treatments: (1) Megalac Plus 3% (MP; 0.4kg/day, containing Ca salt of palm fatty acids and Ca salt of methionine hydroxy analogue), (2) Megapro Gold (MPG; 1.5kg/day, containing Ca salt of palm fatty acids, extracted rapeseed meal and whey permeate), and (3) Control (C; unsupplemented). Cows were supplemented for on average 103 days (range 54-134 days). The average milk yield over the first 12 weeks of lactation was higher (P<0.05) for both fat supplements compared to C and was higher for MP compared to C over the full lactation. Both supplements reduced (P<0.05) milk protein concentration over the first 6 weeks of lactation. MPG increased (P<0.05) conception rate to first service compared to C. Conception rate to first service was similar (P=0.14) on MP compared to C. For pregnancy to second service, C had a higher (P<0.05) conception rate than MP. There were no significant differences between treatments in overall pregnancy rate, services per conception, number of cows served in the first 3 weeks of the breeding season or the 6-weeks in-calf rate. Comparing the combined fat treatments to C resulted in a higher (P<0.05) conception rate to first service for the fat treatments but no significant difference in overall pregnancy rate. In conclusion, fat supplements increased conception rate to first service but did not significantly affect the proportion of cows pregnant at the end of the breeding season.